Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

ITOS

ITEOS THERAPEUTICS INC

ITOS

ITOS (ITEOS THERAPEUTICS INC) is held by 0 institutional investors as of Q3 2025.

No verdict yet — fewer than 2 funds hold ITOS.

Top Holders

Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available
Checking access…
Action
Exited
0(-100.0%)$2.6M0.0%—
0
Exited
0(-100.0%)$1,1960.0%—
0
Exited
0(-100.0%)$5.5M0.0%—
0
Exited
0(-100.0%)$1,4860.0%—
0
Exited
0(-100.0%)$114,3160.0%—
0
Exited
0(-100.0%)$593,8030.0%—
0
Exited
0(-100.0%)$440,4750.0%—
0
Exited
0(-100.0%)$396,2280.0%—
0
Exited
0(-100.0%)$2.1M0.0%—
0
Exited
0(-100.0%)$939,7320.0%—
0
Exited
0(-100.0%)$807,9180.0%—
0
Exited
0(-100.0%)$70,7870.0%—
0
Exited
0(-100.0%)$220,9050.0%—
0
Exited
0(-100.0%)$1.5M0.0%—
0
Exited
0(-100.0%)$2.4M0.0%—
0
Exited
0(-100.0%)$8.3M0.0%—
0
Exited
0(-100.0%)$441,5510.0%—
0
Exited
0(-100.0%)$15,3230.0%—
0
Exited
0(-100.0%)$6.1M0.0%—
0
Exited
0(-100.0%)$205,9100.0%—
0

Showing 1-20 of 75

1 / 4
Latest insider trades
InsiderTradeTraded
Detheux MichelU 94K sh
McGrath YvonneU 46K sh
Call MatthewU 162K sh
Gall MatthewU 89K sh
Feltquate DavidU 47K sh
Detheux MichelU 154K sh
EcoR1 Capital, LLCBuy $26.4M
EcoR1 Capital, LLCBuy $12.3M
GADICKE ANSBERTSell $8.3M
MPM BIOVENTURES 2018, L.P.Sell $5.1M
Loading Congress trades…
Latest activist filings
FilerStakeFiled
Ridgeback Capital Investments L.P.0.0%
TANG CAPITAL MANAGEMENT, LLC100.0%
BIOTECHNOLOGY VALUE FUND L P0.0%
RA Capital Management, L.P.4.9%
EcoR1 Capital, LLC27.9%
TANG CAPITAL MANAGEMENT, LLC10.0%
MPM BioVentures 2014, L.P.1.6%
EcoR1 Capital, LLC14.9%
BlackRock, Inc.5.7%
BlackRock Portfolio Management LLC6.1%
ITOSITOSITEOS THERAPEUTICS INC

Similar stocks

Questions investors ask about ITOS

Who owns ITOS?

0 institutional investors held ITOS on September 30, 2025, according to their 13F filings.

How many hedge funds hold ITOS?

0 institutional investors reported ITOS in their 13F filings for the quarter ended September 30, 2025.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used